Publications by authors named "S Rossenu"

Claim this Profile
T
Translational population target binding model for the anti-FcRn fragment antibody efgartigimod.
Sven Hoefman, Tamara van Steeg, Ingrid Ottevaere, Judith Baumeister, Stefaan Rossenu

J Pharmacokinet Pharmacodyn· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB.
C Kambili, S Rossenu, R M W Hoetelmans, E Birmingham, N Bakare

Int J Tuberc Lung Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug-resistant tuberculosis.
Lénaïg Tanneau, Elin M Svensson, Stefaan Rossenu, Mats O Karlsson

CPT Pharmacometrics Syst Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
M Neyens, H M Crauwels, J J Perez-Ruixo, S Rossenu

J Antimicrob Chemother· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline for multidrug-resistant TB in paediatric patients.
R Moodliar, V Aksenova, M V G Frias, J van de Logt, S Rossenu

Int J Tuberc Lung Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis